Nurix Therapeutics
Discovering drugs for cancer
- B2B
About Nurix Therapeutics
This company discovers drugs targeting ubiquitin E3 ligases to control protein levels for treating cancer and other diseases with novel, small molecules
Key facts
- Industry
- Biotechnology
- Company size
- 251–1,000 employees
- Headquarters
- Brisbane, California, United States
- Founded
- 2012
- Revenue
- $84MFY2025, publicly reported
- Website
- nurixtx.com
- linkedin.com/company/nurixtx
Nurix Therapeutics at a glance
Nurix Therapeutics is a B2B company in the Biotechnology industry, headquartered in Brisbane, California, United States.
Nurix Therapeutics was founded in 2012.
Nurix Therapeutics has 251–1,000 employees.
Nurix Therapeutics's revenue is $84M (FY2025, publicly reported).
Selling to companies like Nurix Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies